Počet záznamov: 1
Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients
SYS 0149202 LBL 00000naa^^22^^^^^^^^450 005 20181011123634.3 100 $a 20180910d2018 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients $f M. Stork ... [et al.] 215 $c ilustr., grafy, tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0149076 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 65, no. 4 (2018), s. 585-591 $1 210 $a Bratislava $c AEPress $d 2018 $1 215 $a s. 477-649 606 1-
$3 sllk_un_auth*d009101 $a myelóm mnohopočetný $x farmakoterapia $x terapia $2 mesh 606 1-
$3 sllk_un_auth*d004358 $a farmakoterapia $x metódy $2 mesh 606 1-
$3 sllk_un_auth*d012008 $a recidíva $2 mesh 606 2-
$3 sllk_un_auth*d018572 $a prežívanie bez choroby $2 mesh 610 2-
$a lenalidomid - použitie terapeutické, účinky nežiaduce 610 2-
$a daratumumab 610 2-
$a pomalidomid 701 -1
$3 sllk_un_auth*0042898 $a Štork $b M. $p Katedra aplikované elektroniky FEL ZČU, Plzeň $4 070 801 -0
$a SK $b BA006 $c 20180910 $g AACR2
Počet záznamov: 1